Testing effectiveness (Phase 2)Looking for participantsNCT06064890
What this trial is testing
Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
Who this might be right for
Frontotemporal DementiaFTDFTD-GRN+1 more
AviadoBio Ltd 18